Development of angiogenesis inhibitors for cancer therapy S. Gail EckhardtJames M. Pluda OriginalPaper Pages: 1 - 3
The preclinical evaluation of angiogenesis inhibitors Michael S. O'Reilly OriginalPaper Pages: 5 - 13
Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy Stephen B. FoxAdrian L. Harris OriginalPaper Pages: 15 - 28
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents Yoshihiro KakejiBeverly A. Teicher OriginalPaper Pages: 39 - 48
An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action William J. Gradishar OriginalPaper Pages: 49 - 59
Matrix metalloproteinase inhibitors Slawomir M. Wojtowicz-PragaRobert B. DicksonMichael J. Hawkins OriginalPaper Pages: 61 - 75
Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action Eugene A. WolteringJames C. WatsonRosemary Barrie OriginalPaper Pages: 77 - 86